Literature DB >> 33887067

The thrombin receptor modulates astroglia-neuron trophic coupling and neural repair after spinal cord injury.

Ha Neui Kim1,2, Erin M Triplet1,2,3, Maja Radulovic1,2, Samantha Bouchal1, Laurel S Kleppe1, Whitney L Simon1, Hyesook Yoon1,2, Isobel A Scarisbrick1,2,3.   

Abstract

Excessive activation of the thrombin receptor, protease activated receptor 1 (PAR1) is implicated in diverse neuropathologies from neurodegenerative conditions to neurotrauma. PAR1 knockout mice show improved outcomes after experimental spinal cord injury (SCI), however information regarding the underpinning cellular and molecular mechanisms is lacking. Here we demonstrate that genetic blockade of PAR1 in female mice results in improvements in sensorimotor co-ordination after thoracic spinal cord lateral compression injury. We document improved neuron preservation with increases in Synapsin-1 presynaptic proteins and GAP43, a growth cone marker, after a 30 days recovery period. These improvements were coupled to signs of enhanced myelin resiliency and repair, including increases in the number of mature oligodendrocytes, their progenitors and the abundance of myelin basic protein. These significant increases in substrates for neural recovery were accompanied by reduced astrocyte (Serp1) and microglial/monocyte (CD68 and iNOS) pro-inflammatory markers, with coordinate increases in astrocyte (S100A10 and Emp1) and microglial (Arg1) markers reflective of pro-repair activities. Complementary astrocyte-neuron co-culture bioassays suggest astrocytes with PAR1 loss-of-function promote both neuron survival and neurite outgrowth. Additionally, the pro-neurite outgrowth effects of switching off astrocyte PAR1 were blocked by inhibiting TrkB, the high affinity receptor for brain derived neurotrophic factor. Altogether, these studies demonstrate unique modulatory roles for PAR1 in regulating glial-neuron interactions, including the capacity for neurotrophic factor signaling, and underscore its position at neurobiological intersections critical for the response of the CNS to injury and the capacity for regenerative repair and restoration of function.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  TrkB; astroglia; brain derived neurotrophic factor; growth cone; myelin; protease activated receptor 1; spinal cord trauma; synapse

Mesh:

Substances:

Year:  2021        PMID: 33887067      PMCID: PMC8672305          DOI: 10.1002/glia.24012

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  69 in total

1.  Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.

Authors:  Scott D Sorensen; Olivier Nicole; Richard D Peavy; Lisa M Montoya; C Justin Lee; T J Murphy; Stephen F Traynelis; John R Hepler
Journal:  Mol Pharmacol       Date:  2003-11       Impact factor: 4.436

2.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

Review 3.  Reactive Astrocytes: Production, Function, and Therapeutic Potential.

Authors:  Shane A Liddelow; Ben A Barres
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 4.  Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Authors:  S R Coughlin
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

5.  Participation of protease-activated receptor-1 in thrombin-induced microglial activation.

Authors:  Zhiming Suo; Min Wu; Syed Ameenuddin; Heidi E Anderson; Jamie E Zoloty; Bruce A Citron; Patricia Andrade-Gordon; Barry W Festoff
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

6.  Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord.

Authors:  L J Noble; J R Wrathall
Journal:  Exp Neurol       Date:  1985-04       Impact factor: 5.330

Review 7.  Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent.

Authors:  Shauna L French; Jane F Arthur; Huyen A Tran; Justin R Hamilton
Journal:  Blood Rev       Date:  2014-11-06       Impact factor: 8.250

8.  Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier.

Authors:  Ha Neui Kim; Yu Ri Kim; Sung Min Ahn; Sun Kyung Lee; Hwa Kyoung Shin; Byung Tae Choi
Journal:  J Neurochem       Date:  2015-09-22       Impact factor: 5.372

9.  Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.

Authors:  Bruce A Citron; Syed Ameenuddin; K Uchida; William Z Suo; Karen SantaCruz; Barry W Festoff
Journal:  Brain Res       Date:  2016-04-30       Impact factor: 3.610

View more
  3 in total

1.  Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood-spinal cord barrier breakdown during acute spinal cord injury in rats.

Authors:  Chenxi Zhao; Tiangang Zhou; Xiaoqing Zhao; Yilin Pang; Wenxiang Li; Baoyou Fan; Ming Li; Xinjie Liu; Lei Ma; Jiawei Zhang; Chao Sun; Wenyuan Shen; Xiaohong Kong; Xue Yao; Shiqing Feng
Journal:  J Neuroinflammation       Date:  2022-07-16       Impact factor: 9.587

2.  1,800 MHz Radiofrequency Electromagnetic Irradiation Impairs Neurite Outgrowth With a Decrease in Rap1-GTP in Primary Mouse Hippocampal Neurons and Neuro2a Cells.

Authors:  Yanqi Li; Ping Deng; Chunhai Chen; Qinlong Ma; Huifeng Pi; Mindi He; Yonghui Lu; Peng Gao; Chao Zhou; Zhixin He; Yanwen Zhang; Zhengping Yu; Lei Zhang
Journal:  Front Public Health       Date:  2021-11-22

3.  Catalpol as a Component of Rehmannia glutinosa Protects Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.

Authors:  Zhiyang Huang; Jiahong Gong; Wen Lin; Zhiyi Feng; Yirou Ma; Yurong Tu; Xiong Cai; Jianhua Liu; Chang Lv; Xinru Lv; Qiuji Wu; Wenjie Lu; Juan Zhao; Yibo Ying; Shengcun Li; Wenfei Ni; Haili Chen
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.